Jersey City, NJ-based pharmaceutical company Organon & Co. has reported a significant change in its executive team. Effective ...

总部位于新泽西州泽西市的制药公司Organon & Co.报告了其高管团队的重大变动。自2025年1月15日起，Susanne Fiedler已立即卸任首席商务官一职。虽然她已停止履行当前职责，但Fiedler将继续担任公司高级顾问，直到她预计于2025年4月30日离职。

Organon has faced significant price volatility and underperformance since its spin-off from Merck. Check out why I recommend ...

周二，TD Cowen维持对Organon & Co. (NYSE:OGN)股票的"持有"评级，设定目标价为19.00美元。此举是在分析师覆盖从Steve Scala转移到Michael Nedelcovych之际。Organon最近分享了其业务运营的更新，其中包括对2025年的预测。

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on Organon (OGN – Research Report), with a price target of ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against the other best medical stocks ...

Organon & Co.’s (NYSE:OGN) largest product, Nexplanon, is expected to generate $1 billion in revenue in 2025. The recent acquisition of Dermavant Sciences Ltd. in October 2024 enhanced the ...

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against the other best medical stocks ...

The most recent trading session ended with Organon (OGN) standing at $14.96, reflecting a +0.27% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a ...